Skip to main content
SpringerLink
Log in

Overview of Metabolic Syndrome

  • Reference work entry
  • First Online:
Metabolic Syndrome

Abstract

The diagnosis of metabolic syndrome is based on the presence of abdominal obesity, increased blood pressure, elevated glucose and triglycerides, and low high-density lipoprotein cholesterol (HDL-C) levels. The prevalence of metabolic syndrome has increased globally mainly due to excessive intake of energy-dense foods and reduced physical activity. Metabolic syndrome increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases, nonalcoholic fatty liver disease (NAFLD), cancer, infertility, dementia, and other diseases. The purpose of this book is to highlight the epidemiology, pathophysiology, clinical features, and treatment of metabolic syndrome. We are hopeful the chapters will provide valuable current insights as well as critical questions to guide future research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med J Br Diabet Assoc. 1998;15(7):539-553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

    Google Scholar 

  • Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366(9491):1059-1062. doi:10.1016/S0140-6736(05)67402-8.

    Google Scholar 

  • Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med J Br Diabet Assoc. 2006;23(5):469-480. doi:10.1111/j.1464-5491.2006.01858.x.

    Google Scholar 

  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644.

    Google Scholar 

  • Albrink MJ, Krauss RM, Lindgrem FT, et al. Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids. 1980;15(9):668-676.

    Google Scholar 

  • Apovian CM, Aronne L, Rubino D, et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity. 2013;21(5):935-943. doi:10.1002/oby.20309.

    Google Scholar 

  • Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278. doi:10.1016/S0140-6736(05)67394-1.

    Google Scholar 

  • Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med J Br Diabet Assoc. 1999;16(5):442-443.

    Google Scholar 

  • Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-1656. doi:10.1056/NEJM199806043382302.

    Google Scholar 

  • Billes SK, Sinnayah P, Cowley MA. Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacol Res Off J Ital Pharmacol Soc. 2014;84:1-11. doi:10.1016/j.phrs.2014.04.004.

    Google Scholar 

  • Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25–26 August 2002, Washington, DC. Diabetes Care. 2003;26(4):1297-1303.

    Google Scholar 

  • Bolinder J, Ljunggren O, Kullberg J, et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab. 2012;97(3):1020-1031. doi:10.1210/jc.2011-2260.

    Google Scholar 

  • Borghi C, Santi F. Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence. Patient Prefer Adherence. 2012;6:449-455. doi:10.2147/PPA.S23232.

    Google Scholar 

  • Brunner EJ, Marmot MG, Nanchahal K, et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia. 1997;40(11):1341-1349. doi:10.1007/s001250050830.

    Google Scholar 

  • Chien KL, Lee BC, Hsu HC, et al. Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: a report on the hospital-based health diagnosis of the adult population. Atherosclerosis. 2008;196(2):764-771. doi:10.1016/j.atherosclerosis.2007.01.006.

    Google Scholar 

  • Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581-590. doi:10.1016/S0140-6736(12)60367-5.

    Google Scholar 

  • Chrysant SG, Chrysant GS, Chrysant C, et al. The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Curr Clin Pharmacol. 2010;5(2):89-95.

    Google Scholar 

  • Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696. doi:10.1016/S0140-6736(04)16895-5.

    Google Scholar 

  • Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157(8):821-827. doi:10.1001/archpedi.157.8.821.

    Google Scholar 

  • Cook S, Auinger P, Li C, et al. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. J Pediatr. 2008;152(2):165-170. doi:10.1016/j.jpeds.2007.06.004.

    Google Scholar 

  • Coomans CP, Geerling JJ, van den Berg SA, et al. The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system. Br J Pharmacol. 2013;170(4):908-918. doi:10.1111/bph.12338.

    Google Scholar 

  • Cruz ML, Weigensberg MJ, Huang TT, et al. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89(1):108-113. doi:10.1210/jc.2003-031188.

    Google Scholar 

  • Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4-7.

    Google Scholar 

  • de Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494-2497. doi:10.1161/01.CIR.0000145117.40114.C7.

    Google Scholar 

  • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-194.

    Google Scholar 

  • Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.

    Google Scholar 

  • Festa A, D’Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47.

    Google Scholar 

  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359.

    Google Scholar 

  • Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem. 2013;24(12):2003-2015. doi:10.1016/j.jnutbio.2013.07.002.

    Google Scholar 

  • Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812-819. doi:10.1016/j.amjmed.2006.02.031.

    Google Scholar 

  • Gill H, Mugo M, Whaley-Connell A, et al. The key role of insulin resistance in the cardiometabolic syndrome. Am J Med Sci. 2005;330(6):290-294.

    Google Scholar 

  • Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438. doi:10.1161/01.CIR.0000111245.75752.C6.

    Google Scholar 

  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404.

    Google Scholar 

  • Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41(6):715-722.

    Google Scholar 

  • Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25(11):2016-2021.

    Google Scholar 

  • Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med J Br Diabet Assoc. 2006;23(4):441-444. doi:10.1111/j.1464-5491.2006.01866.x.

    Google Scholar 

  • Ilanne-Parikka P, Eriksson JG, Lindstrom J, et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004;27(9):2135-2140.

    Google Scholar 

  • Jensen MD, Haymond MW, Rizza RA, et al. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83(4):1168-1173. doi:10.1172/JCI113997.

    Google Scholar 

  • Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49(21):2112-2119. doi:10.1016/j.jacc.2007.01.088.

    Google Scholar 

  • Jorgensen ME, Bjerregaard P, Gyntelberg F, et al. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med J Br Diabet Assoc. 2004;21(11):1237-1242. doi:10.1111/j.1464-5491.2004.01294.x.

    Google Scholar 

  • Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-2304.

    Google Scholar 

  • Koo BK. Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabet Metab J. 2014;38(1):32-34. doi:10.4093/dmj.2014.38.1.32.

    Google Scholar 

  • Laaksonen DE, Niskanen L, Nyyssonen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403-1410. doi:10.1007/s00125-004-1472-x.

    Google Scholar 

  • Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290(17):2271-2276. doi:10.1001/jama.290.17.2271.

    Google Scholar 

  • Lim S, Meigs JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol. 2014;34(9):1820-1826. doi:10.1161/ATVBAHA.114.303035.

    Google Scholar 

  • Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 2011;34(6):1323-1328. doi:10.2337/dc10-2109.

    Google Scholar 

  • Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care. 2006;29(3):685-691.

    Google Scholar 

  • Lucove JC, Kaufman JS, James SA. Association between adult and childhood socioeconomic status and prevalence of the metabolic syndrome in African Americans: the Pitt County Study. Am J Public Health. 2007;97(2):234-236. doi:10.2105/AJPH.2006.087429.

    Google Scholar 

  • Marchesini G, Forlani G, Cerrelli F, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med J Br Diabet Assoc. 2004;21(4):383-387. doi:10.1111/j.1464-5491.2004.01115.x.

    Google Scholar 

  • Mattsson N, Ronnemaa T, Juonala M, et al. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med. 2007;261(2):159-169. doi:10.1111/j.1365-2796.2006.01752.x.

    Google Scholar 

  • Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34(1):216-219. doi:10.2337/dc10-0879.

    Google Scholar 

  • Nestel P, Lyu R, Low LP, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr. 2007;16(2):362-367.

    Google Scholar 

  • Onat A, Hergenc G. Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metab Clin Exp. 2011;60(4):499-512. doi:10.1016/j.metabol.2010.04.018.

    Google Scholar 

  • Onat A, Uyarel H, Hergenc G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 2006;19(10):1055-1062. doi:10.1016/j.amjhyper.2006.02.014.

    Google Scholar 

  • Onat A, Can G, Hergenc G, et al. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome, and in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond). 2007;31(7):1119-1125. doi:10.1038/sj.ijo.0803552.

    Google Scholar 

  • Onat A, Ozhan H, Erbilen E, et al. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol. 2009;135(2):211-217. doi:10.1016/j.ijcard.2008.03.054.

    Google Scholar 

  • Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611-619.

    Google Scholar 

  • Park MJ, Yun KE, Lee GE, et al. A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults. Ann Epidemiol. 2007;17(4):320-326. doi:10.1016/j.annepidem.2006.10.007.

    Google Scholar 

  • Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119(5 Suppl 1):S10-S16. doi:10.1016/j.amjmed.2006.01.009.

    Google Scholar 

  • Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277-2283. doi:10.1001/jama.290.17.2277.

    Google Scholar 

  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.

    Google Scholar 

  • Rubin D, Claas S, Pfeuffer M, et al. s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids Health Dis. 2008;7:32. doi:10.1186/1476-511X-7-32.

    Google Scholar 

  • Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep. 2002;4(6):494-500.

    Google Scholar 

  • Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens. 2006;24(4):621-626. doi:10.1097/01.hjh.0000217840.26971.b6.

    Google Scholar 

  • Silventoinen K, Pankow J, Jousilahti P, et al. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol. 2005;34(2):327-334. doi:10.1093/ije/dyi007.

    Google Scholar 

  • Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245-256. doi:10.1056/NEJMoa0909809.

    Google Scholar 

  • Smith SM, Meyer M, Trinkley KE. Phentermine/topiramate for the treatment of obesity. Ann Pharmacother. 2013;47(3):340-349. doi:10.1345/aph.1R501.

    Google Scholar 

  • Sun SS, Liang R, Huang TT, et al. Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr. 2008;152(2):191-200. doi:10.1016/j.jpeds.2007.07.055.

    Google Scholar 

  • Vilsboll T, Christensen M, Junker AE, et al. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ. 2012;344:d7771. doi:10.1136/bmj.d7771.

    Google Scholar 

  • Wamala SP, Lynch J, Horsten M, et al. Education and the metabolic syndrome in women. Diabetes Care. 1999;22(12):1999-2003.

    Google Scholar 

  • Watanabe S, Tagawa T, Yamakawa K, et al. Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2005;25(11):2376-2380. doi:10.1161/01.ATV.0000187465.55507.85.

    Google Scholar 

  • Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-2374. doi:10.1056/NEJMoa031049.

    Google Scholar 

  • Weng X, Liu Y, Ma J, et al. An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr. 2007;10(2):131-136. doi:10.1017/S1368980007226023.

    Google Scholar 

  • Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251-257. doi:10.1016/j.diabres.2006.12.001.

    Google Scholar 

  • Zreikat HH, Harpe SE, Slattum PW, et al. Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome. Metab Clin Exp. 2014;63(3):392-399. doi:10.1016/j.metabol.2013.11.006.

    Google Scholar 

Download references

Acknowledgment

Supported by American Diabetes Association grant #7-13-BS-004 and National Institutes of Health grants R01-NS084965 and P01-DK049210.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA

    Rexford S. Ahima

  2. Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA

    Rexford S. Ahima

Authors
  1. Rexford S. Ahima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rexford S. Ahima .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Rexford S. Ahima

  2. Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA

    Rexford S. Ahima

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this entry

Cite this entry

Ahima, R.S. (2016). Overview of Metabolic Syndrome. In: Ahima, R.S. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-11251-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-11251-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-11250-3

  • Online ISBN: 978-3-319-11251-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation